Ignite Creation Date:
2024-05-06 @ 6:35 PM
Last Modification Date:
2024-10-26 @ 2:50 PM
Study NCT ID:
NCT05712707
Status:
RECRUITING
Last Update Posted:
2024-06-14
First Post:
2023-01-24
Brief Title:
Sublingual Dexmedetomidine for Treating Opioid Withdrawal
Sponsor:
New York State Psychiatric Institute
Organization:
New York State Psychiatric Institute
Organization Data
Organization:
New York State Psychiatric Institute
Class:
OTHER
Study ID:
8325
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
New York State Psychiatric Institute
Lead Sponsor Class:
OTHER
Responsible Party:
Sandra D Comer
Responsible Party Title:
Clinical Psychiatrist
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
New York State Psychiatric Institute
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| BioXcel Therapeutics Inc | INDUSTRY |
| Yale University | OTHER |
| Clinilabs Inc | OTHER |
| CenExel HRI | UNKNOWN |
| National Institute on Drug Abuse NIDA | NIH |